Exploring the Potential of Phytocannabinoids Against Multidrug-Resistant Bacteria

Exploring the Potential of Phytocannabinoids Against Multidrug-Resistant Bacteria

The rapid emergence of multidrug-resistant (MDR) bacterial pathogens poses a critical threat to global health, creating an urgent need for novel antimicrobial agents. In this study, we evaluated a small library of natural and semisynthetic phytocannabinoids against a broad panel of MDR Gram-positive...

Full description

Saved in:

Bibliographic Details
Main Authors:	Carmina Sirignano, Simona De Vita, Ernesto Gargiulo, Massimiliano Lucidi, Daniela Visaggio, Maria Giovanna Chini, Gianluigi Lauro, Giuseppina Chianese, Paolo Visca, Giuseppe Bifulco, Orazio Taglialatela-Scafati
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Plants
Subjects:	multidrug resistance cannabinoids inverse virtual screening antibacterial activity
Online Access:	https://www.mdpi.com/2223-7747/14/13/1901
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Phytocannabinoids as Chemotherapy Adjuncts—A Review for Users
by: Gerhard Nahler
Published: (2024-10-01)

Recent Preclinical Evidence on Phytocannabinoids in Neurodegenerative Disorders: A Focus on Parkinson’s and Alzheimer’s Disease
by: Nicoleta-Mirela Blebea, et al.
Published: (2025-06-01)

Uncovering the molecular targets of phytocannabinoids: mechanistic insights from inverse molecular docking fingerprint approaches
by: Vid Ravnik, et al.
Published: (2025-06-01)

Therapeutic Potential of Cannabinoids in Glaucoma – Hit or Myth? - A Review
by: Julia Górny, et al.
Published: (2024-11-01)

Chemical Profiling of Polyphenolic Fraction of <i>Cannabis sativa</i> L. vr. <i>Kompolti</i> Industrial Inflorescences: Insights into Cannabidiol Neuroprotective Effects in a Cellular Model of Parkinson’s Disease
by: Francesca Fantasma, et al.
Published: (2025-05-01)

Pharmacokinetics of Non-Psychotropic Phytocannabinoids
by: Mariana Lacerda, et al.
Published: (2025-02-01)

The role of cannabinoid agonists and antagonists on folliculogenesis and evolutionary events in the mouse ovary
by: Vida Mirzaie, et al.
Published: (2025-09-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

Bedaquiline and linezolid regimens for multidrug-resistant tuberculosis: a systematic review and meta-analysis
by: Mahdis Cheraghi, et al.
Published: (2025-03-01)

THE EFFICIENCY OF TREATMENT IN MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS REGISTERED IN 2010
by: S. A. Sterlikov, et al.
Published: (2014-03-01)

Design, Development, and Method Evaluation of Aptamer-Based Diagnostics for the Detection of Multidrug-Resistant Bacteria
by: N. Jaya Lakshmi, et al.
Published: (2024-04-01)

Phytocanabinoids and synthetic cannabinoids: from recreational consumption to potential therapeutic use – a review
by: Helena M. Teixeira, et al.
Published: (2025-01-01)

Cannabinoid hyperemesis syndrome: genetic susceptibility to toxic exposure
by: Ethan B. Russo, et al.
Published: (2024-10-01)

RESULTS OF CHEMOTHERAPY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS IN THE REGIONS OF THE RUSSIAN FEDERATION
by: V. V. Testov, et al.
Published: (2014-04-01)

Multidrug-Resistant Acinetobacter baumannii mediastinitis
by: Selman Dumani, et al.
Published: (2024-07-01)

Cryo-EM structure of the Pseudomonas aeruginosa MexY multidrug efflux pump
by: William D. Gregor, et al.
Published: (2025-04-01)

RISK FACTORS FOR INEFFECTIVE CHEMOTHERAPY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS
by: O. V. Filinyuk, et al.
Published: (2014-01-01)

Multidrug-Resistant Bacteria in Immunocompromised Patients
by: Alexandru Duhaniuc, et al.
Published: (2024-08-01)

A Rare Presentation of Acute Multifocal Skeletal Multidrug-resistant Tuberculosis
by: Rahul Puli, et al.
Published: (2023-04-01)

Defects in the statistical accounting of patients with tuberculosis with its multidrug-resistant pathogen
by: V. B. Galkin
Published: (2015-02-01)

Tigecycline therapy for multidrug-resistant bacteria: is it the right choice for pediatric patients
by: Gulhadiye Avcu, et al.
Published: (2025-07-01)

Effectivity of Uniform Multidrug Therapy on the Success of Paucibacillary and Multibacillary Leprosy Treatment
by: Prayogi Miura Susanto, et al.
Published: (2022-09-01)

Effectivity of Uniform Multidrug Therapy on the Success of Paucibacillary and Multibacillary Leprosy Treatment
by: Prayogi Miura Susanto, et al.
Published: (2022-09-01)

Divide and conquer: processive transport enables multidrug transporters to tackle challenging drugs
by: Nir Fluman, et al.
Published: (2014-09-01)

Effectiveness of using Glutamyl-cysteinyl-glycine disodium immunomodulator in patients with destructive multidrug-resistant tuberculosis of lungs
by: A. S. Shalmin, et al.
Published: (2015-08-01)

Long-term results of treatment in multidrug-resistant mycobacterium tuberculosis patients interrupting a chemotherapy cycle
by: A. I. Gaida, et al.
Published: (2014-12-01)

Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy
by: MariaLuisa Vigano, et al.
Published: (2025-03-01)

Multidrug-resistant osteosarcoma: A systematic review
by: Mokhtar Ahmed Alsayed, et al.
Published: (2025-01-01)

Evaluation of the metabolic activity, angiogenic impacts, and GSK-3β signaling of the synthetic cannabinoid MMB-2201 on human cerebral microvascular endothelial cells
by: Laith Naser AL-Eitan, et al.
Published: (2024-12-01)

Update on multidrug-resistant tuberculosis preventive therapy toward the global tuberculosis elimination
by: Alberto Matteelli, et al.
Published: (2025-06-01)

Affecting of Hypervirulent Multidrug Resistant Klebsiella pneumoniae on Public Health
by: Ali abd kadhum
Published: (2025-06-01)

Phytocannabinoids: a new frontier in Alzheimer’s disease management
by: Jagadeesh S. Rao
Published: (2024-09-01)

Cannabinoid Regulation of Murine Vaginal Secretion
by: Natalia Murataeva, et al.
Published: (2025-03-01)

Pharmacokinetics of Oral Cannabinoid Δ8-Tetrahydrocannabivarin and Its Main Metabolites in Healthy Participants
by: Cristina Sempio, et al.
Published: (2024-11-01)

Cannabinoids in Neurology - Position paper from Scientific Departments from Brazilian Academy of Neurology
by: Sonia Maria Dozzi BRUCKI, et al.
Published: (2021-06-01)

How Cannabinol Is Utilized in Japan, a Country with Strict Cannabis Regulations—Its Purposes, Medical Effects, Adverse Events, and Dependence
by: Yuji Masataka, et al.
Published: (2024-03-01)

Structural changes in the wall of the abdominal aorta in modeling of long-term cannabinoid receptors CB1 blockade in laboratory animals
by: S. V. Havreliuk
Published: (2019-06-01)

Comorbidity in phthisiatric practice: multidrug-resistant tuberculosis and laryngeal cancer (2 case reports)
by: O. M. Raznatovska, et al.
Published: (2020-02-01)

Efficiency of surgical treatment of multidrug-resistant Pulmonary Tuberculosis within the DOTS-PLUS program
by: A. K. Strelis, et al.
Published: (2009-02-01)